Iinuma, K.; Tomioka-Inagawa, R.; Kameyama, K.; Taniguchi, T.; Kawada, K.; Ishida, T.; Nagai, S.; Enomoto, T.; Ueda, S.; Kawase, M.;
et al. Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Biomedicines 2022, 10, 3172.
https://doi.org/10.3390/biomedicines10123172
AMA Style
Iinuma K, Tomioka-Inagawa R, Kameyama K, Taniguchi T, Kawada K, Ishida T, Nagai S, Enomoto T, Ueda S, Kawase M,
et al. Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Biomedicines. 2022; 10(12):3172.
https://doi.org/10.3390/biomedicines10123172
Chicago/Turabian Style
Iinuma, Koji, Risa Tomioka-Inagawa, Koji Kameyama, Tomoki Taniguchi, Kei Kawada, Takashi Ishida, Shingo Nagai, Torai Enomoto, Shota Ueda, Makoto Kawase,
and et al. 2022. "Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study" Biomedicines 10, no. 12: 3172.
https://doi.org/10.3390/biomedicines10123172
APA Style
Iinuma, K., Tomioka-Inagawa, R., Kameyama, K., Taniguchi, T., Kawada, K., Ishida, T., Nagai, S., Enomoto, T., Ueda, S., Kawase, M., Takeuchi, S., Kawase, K., Kato, D., Takai, M., Nakane, K., & Koie, T.
(2022). Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Biomedicines, 10(12), 3172.
https://doi.org/10.3390/biomedicines10123172
